Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bristol-Myers Squibb
Age
18–49
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Healthy men and women, ages 18 to 49 years
Body mass index 18 to 32 kg/m\^2, inclusive
Women of childbearing potential (WOCBP) who were not pregnant or breastfeeding
WOCBP and men who are sexually active with WOCBP must use acceptable contraceptive methods
You may not be if
Any significant acute or chronic medical illness
Current or recent (within 3 months of study drug administration) gastrointestinal tract disease
Any major surgery within 4 weeks of study drug administration
Any gastrointestinal tract surgery (including cholecystectomy) that could have an impact on the absorption of study drug
Donation of blood to a blood bank or in a clinical study (except a screening visit) within 4 weeks of study drug administration (within 2 weeks for plasma only)
Blood transfusion within 4 weeks of study drug administration
Inability to tolerate oral medication, to be venipunctured, or to tolerate venous access
Evidence of organ dysfunction or any clinically significant deviation from normal in physical examination or electrocardiogram (ECG) findings, vital sign measurements, or results of clinical laboratory tests, beyond what is consistent with the target population
Any of the following 12-lead ECG findings prior to study drug administration, confirmed by repeat testing
* PR ≥210 msec
* QRS ≥120 msec
* QT ≥500 msec
* QTcF ≥450 msec
2nd- or 3rd-degree A-V block or clinically relevant abnormalities in ECG findings
Positive result on urine screening for drugs of abuse
Positive result on blood screening for hepatitis C antibody, hepatitis B surface antigen, or HIV-1 or -2 antibody
Laboratory test results indicating levels outside of the ranges specified below:
* Alanine aminotransferase \>upper limit of normal (ULN)
